According to TCGA, grade II gliomas showing high expression levels of H3-3B tend to accumulate more somatic mutations in the ATRX and TP53 genes (Figure 3A), which are most frequently found in astrocytomas with IDH mutations [33]. This evidence concerns the gene TP53 and central nervous system cancer.